Rolled oats in a bowl.

Oats

Q: Do oats lower cholesterol?

A little, on average. In a pooled analysis of 28 randomized trials, oat beta-glucan lowered LDL cholesterol by 0.25 mmol/L, and a later review of 58 trials found 0.19 mmol/L, with big differences between trials. That is a change in a blood marker, not proof of fewer heart attacks.

Q: Can oats prevent heart disease?

This was not shown. The cholesterol trials measured a blood marker. A pooled analysis of 8 cohort studies found no statistically significant link between oat intake and cardiovascular disease, and cohort studies cannot show cause.

Q: What does the US heart-health label on oats mean?

It is a labelling rule. US regulations allow a claim that diets low in saturated fat and cholesterol that include beta-glucan soluble fibre from whole oats or barley may reduce the risk of heart disease, and list oat bran, rolled oats and whole oat flour as eligible forms. It is not a personal recommendation.

Q: Do oats help with blood sugar or diabetes?

The evidence is mixed. Short trials in people with type 2 diabetes found small drops in fasting glucose and HbA1c with oat beta-glucan, but a 16-week trial in adults at risk of diabetes found no change with beta-glucan-enriched bread. Cohort studies link higher oat intake with lower type 2 diabetes risk, which cannot prove cause. Ask your care team if you take diabetes medicine.

Q: Does it matter which kind of oats I choose?

For after-meal blood sugar, a pooled analysis of test meals found intact kernels and thick flakes lowered the glucose and insulin rise but thin, quick or instant flakes did not (authors linked to Quaker Oats and PepsiCo). No source read compared instant, rolled and steel-cut oats for cholesterol. Flavoured packets may have added sugar, so check the label.

Q: Are oats gluten-free?

Oats themselves do not contain gluten, but the NHS says they can cause a reaction if produced in the same place as wheat, barley and rye. In the US, oats labelled "gluten-free" must contain less than 20 ppm gluten.

Q: Can I eat oats if I have celiac disease?

Ask your clinician or dietitian first. A Health Canada review concluded that oats not contaminated with wheat, rye or barley can be safely eaten by most people with celiac disease, while a few seem intolerant to oats, and it advises waiting until symptoms have settled and a gluten-free diet has been followed for at least 6 months.

Q: Are oats safe to eat if they have been stored damp?

No. WHO says moulds on cereals can produce toxins, names T-2 and HT-2 toxins as associated with oats, and advises keeping grain dry and not too warm and throwing away mouldy food.

Q: Can oats cause gas or bloating?

They might in some people. NIDDK explains that fibre and other carbohydrates the small intestine does not fully digest are broken down by gut bacteria, which makes gas. That is a general statement; oats are not named on the page.

Avena sativa · also called Oatmeal, rolled oats, oat groats

Oats are a whole grain that contains beta-glucan, a soluble fibre. In pooled trials, oat beta-glucan lowered LDL cholesterol a little, but that is a blood marker and not proof of fewer heart attacks. Evidence for blood sugar is mixed, and links with heart disease in large studies are not statistically significant. The main caution is gluten cross-contact for people with celiac disease.

General information, not medical advice. Last substantive update October 26, 2026 · Not medically reviewed. A named clinician has not signed off on this page. How this page is made

About Oats

Oats are a whole grain with soluble fibre called beta-glucan. They are a food, not a proven remedy: the cholesterol findings are small changes in a blood marker, the blood sugar findings are mixed, and the heart disease link is not statistically significant in cohort studies.

What it is

Oats are the grain of the oat plant (Avena sativa), eaten as a whole grain. The edible part is the groat. A US rule defines rolled oats ("also known as oatmeal") as made from dehulled, clean groats by steaming, cutting, rolling and flaking.

USDA data for regular and quick oats cooked with water, per 100 g: 71 kcal, 2.54 g protein, 1.52 g fat, 12.0 g carbohydrate, 1.7 g fibre, 27 mg magnesium, 77 mg phosphorus and 0.58 mg manganese. A cup (234 g) has about 166 kcal, 6 g protein, 4 g fibre and 63 mg magnesium. Dry oats, per 100 g, have 379 kcal, 13.2 g protein and 10.1 g fibre, because cooking adds water.

^{14 12 18 17}

What the research shows

The firmest finding is about cholesterol. A 2014 pooled analysis of 28 randomized trials found oat beta-glucan lowered LDL by 0.25 mmol/L and total cholesterol by 0.30 mmol/L, with no significant effect on HDL or triglycerides. A 2016 review of 58 trials found a smaller LDL fall of 0.19 mmol/L, with large unexplained differences between trials. These are blood markers, and the trials were short.

Blood sugar results are mixed. Four short trials in people with type 2 diabetes found lower fasting glucose and HbA1c. A 2025 trial in 194 adults at risk of diabetes found beta-glucan-enriched bread did not change HbA1c, fasting glucose, insulin or LDL over 16 weeks. In single-meal tests, intact kernels and thick flakes lowered the glucose and insulin rise, but thin, quick or instant flakes did not; that pooled analysis was by authors linked to Quaker Oats and PepsiCo.

In cohort studies (471,157 people), the highest oat intake went with lower type 2 diabetes risk (RR 0.78) but no significant link with cardiovascular disease. These can show links, not cause, and the analysis was supported by a supplement company. Studies of whole grains in general link them with lower heart disease risk, but the abstracts do not report oats separately.

^{10 3 8 2 6 9 1 7}

The US heart-health label rule

US regulations allow a health claim that diets low in saturated fat and cholesterol that include soluble fibre from certain foods may reduce the risk of heart disease. The rule names 3 g or more per day of beta-glucan soluble fibre from whole oats or barley, and lists oat bran, rolled oats and whole oat flour as eligible forms with minimum beta-glucan content (at least 4% of dry weight for rolled oats and whole oat flour, 5.5% for oat bran).

This is a labelling rule, not a personal recommendation. Your clinician or dietitian decides what is right for you.

¹²

Does it matter which oats?

The cholesterol trials studied beta-glucan in oat foods and products, and the abstracts do not compare instant, rolled and steel-cut oats. For after-meal blood sugar, less processed oats (intact kernels and thick flakes) did better than thin, quick or instant flakes in one industry-linked analysis. Flavoured packets may contain added sugar, so check the label.

^{10 3 6}

Food versus extracts and supplements

The cholesterol results are for oat beta-glucan given in oat foods and products. The 2025 blood sugar trial used bread enriched with beta-glucan, not plain oats. Oat extracts, beta-glucan concentrates and avenanthramide products are different from eating oats and are not covered by the food results here.

^{10 2 11}

At a glance

Traditional uses history, not proof

Eaten as a whole-grain food
Long use as food is not proof that it treats any condition

Studied for research

Fibre, protein and minerals, high certainty for the nutrient content (USDA)
Cholesterol, moderate certainty (pooled trials of oat beta-glucan, a blood marker)
Blood sugar over weeks, mixed (short trials and one null 16-week trial)
After-meal blood sugar and oat form, low certainty (industry-linked single-meal tests)
Type 2 diabetes, heart disease and early death, low certainty (observational)
Whole grains in general, low certainty (observational, oats not reported separately)
Avenanthramides, insufficient evidence (lab and animal only)
Digestive health, insufficient evidence (no oat-specific trial read)

Main compounds

Beta-glucan (soluble fibre)
Avenanthramides (oat-specific)
Starch
Protein
Magnesium, manganese, phosphorus and zinc

Common forms

Regular and quick oats, dry and cooked with water, without salt (USDA values read)
Rolled oats, oat bran and whole oat flour (eligible forms in the US heart-health label rule)
Intact oat kernels, thick flakes and thin, quick or instant flakes (compared for after-meal blood sugar)
Steel-cut oats, flavoured instant packets, oat extracts and beta-glucan products were not read; extracts and concentrates are different from food

Research links: 2014 pooled analysis: oat beta-glucan and cholesterol (28 trials) · 2016 pooled analysis: oat beta-glucan, LDL and apoB (58 trials) · 2016 review: celiac disease and gluten-free oats · Research Library · Genes & Biomarkers Library

What it is and its history

Accepted scientific name: Avena sativa L.
Naming authority: L. (GBIF accepted; the plant whose grain is eaten as oats)
Common names: Oats (English); Oatmeal (English); Rolled oats (English); Oat groats (English); Avena (Spanish)
Family or group: Poaceae (the grass family), as given by GBIF. Oats are the grain of this plant eaten as a whole grain.
Classification: Plantae > Tracheophyta > Liliopsida > Poales > Poaceae > Avena > Avena sativa
Native range: Not verified from a source read.
Habitat: Not verified from a source read.
What it looks like: Roots: Not verified.; Stems: Not verified.; Leaves: Not verified.; Flowers: Not verified.; Fruit: The edible part is the grain, called the groat. USDA gives household portions of 1 cup cooked oatmeal (234 g) and 1 cup of dry oats (81 g).
Cultivation: Not verified from a source read.
Harvest and processing: The US rule read (21 CFR 101.81) defines rolled oats ("also known as oatmeal") as produced from 100 percent dehulled, clean oat groats by steaming, cutting, rolling and flaking; whole oat flour as dehulled groats steamed and ground with no significant loss of oat bran; and oat bran as the fraction of ground groats or rolled oats that is not more than 50 percent of the starting material. A 2021 pooled analysis grouped test oats as intact kernels, thick flakes (over 0.6 mm) and thin, quick or instant flakes. How steel-cut oats and instant oats are made was not read from a source.
Look-alikes and adulterants: Name: Oat bran, oat milk and oat straw; Note: Other oat products with their own pages. Oat bran is the outer layer of the grain; oat milk is a drink; oat straw is a herbal product from the green plant. They differ in nutrients and in what research applies.; Name: Barley; Note: The other grain named with oats in the US beta-glucan heart-health label rule.; Name: Beta-glucan supplements and oat extracts; Note: Not the same as oats as food; several trials used enriched products.
Sustainability and conservation: Not assessed.

Photographs

What is inside, and how it may work

What it contains and how those compounds act in cells and animals. Laboratory and animal mechanisms are not proven effects in people.

Main compounds

Compound	Family	Where it is concentrated	Activity studied	Level of evidence
Oat beta-glucan	soluble dietary fibre (polysaccharide)	Grain, especially the bran Not in the USDA tables read. The US rule sets minimum content for eligible forms: at least 4% (dry weight) for rolled oats and whole oat flour, and at least 5.5% (dry weight) for oat bran. These are label definitions, not measured values for a product.	A viscous soluble fibre; in pooled trials oat beta-glucan lowered LDL cholesterol a little and in some trials fasting glucose and HbA1c. ^{10 3 12}	Human data
Avenanthramides	phenolic amides (unique to oats)	Grain Not found in the sources read.	Cell and animal studies show effects on inflammation and metabolism. Human oral bioavailability is under 2%, and no avenanthramide-specific health effect has been established. ^{11 5}	Lab
Starch	carbohydrate	Grain USDA per 100 g: 57.9 g in dry oats; 11.6 g in oats cooked with water	The main carbohydrate. How quickly it is digested may depend on how much the kernel has been broken up. ^{17 18 6}	Human data
Protein	protein	Grain USDA per 100 g: 13.2 g in dry oats; 2.54 g in oats cooked with water	A nutrient amount; no effect was tested. ^{17 18}	Nutrient database
Total dietary fibre	fibre	Grain USDA per 100 g: 10.1 g in dry oats; 1.7 g in oats cooked with water	Includes beta-glucan. Gut bacteria break down fibre that is not digested, which makes gas. ^{17 18 16}	Nutrient database
Manganese, magnesium, phosphorus and zinc	minerals	Grain USDA per 100 g dry oats: manganese 3.63 mg, magnesium 138 mg, phosphorus 410 mg, zinc 3.64 mg. Cooked with water: manganese 0.58 mg, magnesium 27 mg, phosphorus 77 mg, zinc 1.0 mg	Nutrient amounts; absorption from oats was not read. ^{17 18}	Nutrient database

Mechanisms, receptors and pathways

Target or pathway	Gene or receptor	What was found	Level
Viscous soluble fibre and cholesterol	Not specified in the sources read	The pooled-trial abstracts describe oat beta-glucan as a viscous soluble fibre recognised for cholesterol-lowering properties. The step-by-step way it lowers cholesterol was not described in the abstracts read. ^{3 10}	Human data
Oat kernel structure and after-meal blood sugar	Not specified in the sources read	A pooled analysis of test meals found intact kernels and thick flakes lowered the after-meal glucose and insulin rise but thin, quick or instant flakes did not; the authors say breaking up the kernel is likely linked to losing the benefit. The authors are linked to an oat maker. ⁶	Human data
Avenanthramides, inflammation and gut digestion	NF-kB pathway named in a review; no receptor specified	In cell and animal models avenanthramides influence NF-kB-related inflammation, redox balance, liver insulin signalling, fat metabolism and gut ecology, and in digestion they may modulate starch breakdown and glucose transport. Reviews say these pathways need confirmation in human studies. ^{11 5}	Lab

Absorption, metabolism and elimination

Absorption: For avenanthramides, human studies consistently report very low oral bioavailability (under 2%). For beta-glucan and oat minerals, no absorption data were read.
Distribution: Not found.
Metabolism: Gut microbes turn avenanthramides into dihydro forms, according to a 2026 review; this is a proposal that needs human confirmation.
Elimination: Not found.
Bioavailability: Under 2% for avenanthramides (human studies as summarised by a review). Not established for oat minerals in the sources read.

⁵

Isolated compounds versus whole extracts

The cholesterol results are for oat beta-glucan given in oat foods and products. The 2025 blood sugar trial used bread enriched with oat beta-glucan, not plain oats, and compared it with whole-grain wheat bread. The after-meal results are for oat kernels and flakes. The whole-grain heart disease results are about whole grains in general. Oat extracts, beta-glucan concentrates and avenanthramide products are not the same as eating oats and are not covered by the food results.

Nutritional composition

USDA FoodData Central values read 2026-10-26 (SR Legacy). Dry regular or quick oats (FDC 173904), per 100 g: 379 kcal, 13.2 g protein, 6.52 g fat (1.11 g saturated), 67.7 g carbohydrate, 10.1 g fibre, 52 mg calcium, 4.25 mg iron, 138 mg magnesium, 410 mg phosphorus, 362 mg potassium, 6 mg sodium, 3.64 mg zinc, 3.63 mg manganese, 28.9 micrograms selenium. Oats cooked with water, without salt (FDC 173905), per 100 g: 71 kcal, 2.54 g protein, 1.52 g fat (0.31 g saturated), 12.0 g carbohydrate, 1.7 g fibre, 9 mg calcium, 0.9 mg iron, 27 mg magnesium, 77 mg phosphorus, 70 mg potassium, 4 mg sodium, 1.0 mg zinc, 0.58 mg manganese, 5.4 micrograms selenium. One typical USDA portion of 1 cup cooked (234 g, the 100 g values multiplied by 2.34): about 166 kcal, 5.9 g protein, 3.6 g fat, 28.1 g carbohydrate, 4.0 g fibre, 21 mg calcium, 2.1 mg iron, 63 mg magnesium, 180 mg phosphorus, 2.3 mg zinc, 1.36 mg manganese and 9.4 mg sodium. The same oats are far denser dry than cooked, because cooking adds water (83.6 g water per 100 g cooked, 10.8 g dry); 1 cup of dry oats is 81 g in USDA tables. The USDA tables read have no separate beta-glucan line. Instant packets with added sugar or flavour, steel-cut oats, oat bran and oat flour were not read here.

8benefits and uses looked at

19studies and sources checked

High certaintybest evidence rating found

8lab markers tracked in trials

1 high certainty1 moderate certainty1 mixed findings3 low certainty2 not enough evidence

What was looked at

The 8 benefits and uses checked for Oats, each with how strong the evidence is. Tap one to open it.

Fibre, protein and minerals (nutrient content)High certainty
Cholesterol (oat beta-glucan)Moderate certainty
Blood sugar over weeks (type 2 diabetes and people at risk)Mixed findings
After-meal blood sugar and how the oats are processedLow certainty
Oat intake, type 2 diabetes, heart disease and early death (observational)Low certainty
Whole grains and fibre in general (not oats alone)Low certainty
Avenanthramides (oat-specific compounds)Not enough evidence
Digestive healthNot enough evidence

Lab markers tracked in the studies

LDL cholesterolTotal cholesterolHDL cholesterolTriglyceridesNon-HDL cholesterol and apolipoprotein BBlood glucose (fasting and after meals)HbA1c (average blood sugar over about 3 months)Insulin (fasting and after meals)

What is Oats good for?

The main studied uses and how strong the human evidence is for each. Most trials tested oat beta-glucan or oat products, so results do not all apply to every kind of oats.

Fibre, protein and minerals (nutrient content)High certaintyOats cooked with water have 1.7 g of fibre, 2.54 g of protein and 27 mg of magnesium per 100 g (USDA). A 234 g cup has about 4 g of fibre and 6 g of protein. Dry oats are far more concentrated: 10.1 g of fibre and 13.2 g of protein per 100 g. A nutrient fact, not a trial. Cholesterol (oat beta-glucan)Moderate certaintyIn 28 trials oat beta-glucan lowered LDL by 0.25 mmol/L and total cholesterol by 0.30 mmol/L, with no significant change in HDL or triglycerides. A later review of 58 trials found a smaller LDL fall (0.19 mmol/L) with large differences between trials. A blood marker, not fewer heart attacks. Blood sugar over weeksMixed findingsMixed. Four short trials in 350 people with type 2 diabetes found lower fasting glucose and HbA1c with oat beta-glucan. A 16-week trial in 194 adults at risk of diabetes found beta-glucan-enriched bread did not change HbA1c, fasting glucose, insulin or LDL. After-meal blood sugar and how the oats are processedLow certaintyIn single-meal tests, intact kernels and thick flakes gave a smaller glucose and insulin rise than refined grain; thin, quick or instant flakes did not. The authors are linked to Quaker Oats and PepsiCo. Type 2 diabetes, heart disease and early death (observational)Low certaintyIn 8 cohorts (471,157 people), the highest oat intake went with lower type 2 diabetes risk (RR 0.78). No significant link was found with cardiovascular disease, coronary heart disease or stroke. An association, not proof of cause; a supplement company supported the analysis. Whole grains and fibre in general (not oats alone)Low certaintyPooled observational studies link more whole grain with lower coronary heart disease (RR 0.81 per 90 g a day) and lower all-cause death (RR 0.83). The abstracts do not report oats separately. Avenanthramides (oat-specific compounds)Not enough evidenceCell and animal studies suggest effects on inflammation and metabolism, but people absorb under 2% and no health effect has been proven in people. Lab and animal findings only. Digestive healthNot enough evidenceNo oat-specific trial on bowel regularity or gut symptoms was read, so the evidence for oats is insufficient. A gap, not a negative finding.

Benefits, one by one

Each card is a research question, not a promise. Tap a goal to filter. Open a card to see the studies, doses and limits.

Fibre, protein and minerals (nutrient content)

High certainty

Oats cooked with water have 4.0 g of fibre, 5.9 g of protein, 63 mg of magnesium and 1.36 mg of manganese in a 234 g cup (USDA). Dry oats are much more concentrated. This is what the food contains, not a trial of a health effect.

2 studiesRegular and quick oats, dry and cooked with water, without salt (USDA…

Studies, doses and limits

What the trials found

No trial was read showing that eating oats corrects a low fibre, protein or mineral intake.

Results

Oats are a whole-grain food with fibre, some protein and several minerals. The amounts depend on whether they are dry or cooked.

Effect sizes as reported

USDA, oats cooked with water, per 100 g: 71 kcal, 2.54 g protein, 1.7 g fibre, 27 mg magnesium, 77 mg phosphorus, 0.58 mg manganese, 0.9 mg iron, 9 mg calcium. USDA, dry oats, per 100 g: 379 kcal, 13.2 g protein, 10.1 g fibre, 138 mg magnesium, 410 mg phosphorus, 3.63 mg manganese, 4.25 mg iron, 52 mg calcium.

Why this rating

High that the food contains these nutrients (USDA data). Not tested as a treatment for any deficiency.

Form and dose studied

Regular and quick oats, dry and cooked with water, without salt (USDA items read). Flavoured packets, steel-cut oats and oat bran were not read.

Who was studied

General adult diet.

Limits

Nutrient facts, not trials. Whether the minerals in oats are absorbed as well as the numbers suggest was not read. Products differ by brand and by added ingredients.

Why researchers looked

People eat oats as a whole grain, for fibre and as a source of protein and minerals.

Traditional use

Traditional uses of oats are not described in the sources read, so none are described here. Long use as a food is not proof that it treats any condition.

Proposed mechanism Nutrient database

These are nutrient amounts in the food, taken from USDA tables.

A proposed mechanism does not show that the effect happens in people.

Oats are covered under Safety for gluten cross-contact.

^{17 18}

Cholesterol (oat beta-glucan)

Moderate certainty

Two large pooled analyses of randomized trials found that oat beta-glucan, the soluble fibre in oats, lowered LDL ("bad") cholesterol a little: by 0.25 mmol/L in 28 trials and by 0.19 mmol/L in 58 trials. HDL cholesterol and triglycerides did not change significantly. This is a blood marker, not fewer heart attacks.

3 studiesBeta-glucan from oat foods and oat products (the pooled trials used s…

Studies, doses and limits

What the trials found

Whitehead 2014 pooled 28 randomized trials of at least 3 g a day of oat beta-glucan against control diets (2 to 12 weeks). Ho 2016 pooled 58 trials (3,974 people, at least 3 weeks, median 3.5 g a day). Both found lower LDL, and Ho also found lower non-HDL cholesterol and apoB.

Results

A small but consistent lowering of LDL and total cholesterol in pooled trials. The LDL fall was larger when starting LDL was higher. Trials differ a lot from one another (Ho: I2 79% for LDL).

Effect sizes as reported

Whitehead 2014: LDL -0.25 mmol/L (95% CI -0.30 to -0.20), total cholesterol -0.30 mmol/L (-0.35 to -0.24), no significant change in HDL or triglycerides. Ho 2016: LDL -0.19 mmol/L (-0.23 to -0.14), non-HDL -0.20 mmol/L, apoB -0.03 g/L.

Why this rating

Moderate by our reading: two pooled analyses of randomized trials agree on direction, but the trials were short, many used oat products with a set beta-glucan content, differences between trials were large, and the outcome is a blood marker rather than heart disease. Neither abstract gives a formal GRADE rating.

Form and dose studied

Beta-glucan from oat foods and oat products (the pooled trials used several products and amounts, from about 3 g to 12.4 g of beta-glucan a day). The abstracts do not compare instant, rolled and steel-cut oats for cholesterol.

Who was studied

Adults in randomized trials; Whitehead also looked at people with and without diabetes.

Limits

LDL cholesterol is a risk marker, not a heart attack or stroke. Trials were 2 to 12 weeks. Whitehead searched company in-house reports as well as databases. Not every pooled trial used plain oats; some used oat-enriched products.

Why researchers looked

Oats are rich in beta-glucan, a viscous soluble fibre recognised for cholesterol-lowering properties, and cholesterol is a main risk marker for heart disease.

Traditional use

Traditional uses of oats are not described in the sources read, so none are described here. Long use as a food is not proof that it treats any condition.

Proposed mechanism Authoritative guidance

The abstracts describe beta-glucan as a viscous, soluble fibre. Exactly how it lowers cholesterol was not described in the abstracts read.

A proposed mechanism does not show that the effect happens in people.

None specific to cholesterol. See Safety for gluten, mould toxins and medicine questions.

^{10 3 12}

Blood sugar over weeks (type 2 diabetes and people at risk)

Mixed findings

Results are mixed. A 2016 pooled analysis of 4 short trials in 350 people with type 2 diabetes found oat beta-glucan lowered fasting glucose and HbA1c. A 2025 trial in 194 adults at risk of diabetes found beta-glucan-enriched bread did not change HbA1c, fasting glucose, insulin or LDL over 16 weeks.

2 studiesOat beta-glucan (Shen) and beta-glucan-enriched bread (Hjorth), not p…

Studies, doses and limits

What the trials found

Shen 2016 pooled 4 articles (350 people with type 2 diabetes, 2.5 to 3.5 g beta-glucan a day, 3 to 8 weeks). Hjorth 2025 was a 16-week randomized double-blind trial in 194 adults at risk of type 2 diabetes using bread with 6 g beta-glucan a day against whole-grain wheat bread.

Results

Small drops in short trials in people with diabetes; no change in a longer real-life trial in people at risk. The 2025 authors say the bread swap may not be enough to improve blood sugar control.

Effect sizes as reported

Shen 2016: fasting glucose -0.52 mmol/L (95% CI -0.94 to -0.10), HbA1c -0.21% (-0.40 to -0.02), fasting insulin not significant. Hjorth 2025: HbA1c -0.01% (-0.03 to 0.06), fasting glucose -0.02 mmol/L, insulin -0.76 pmol/L, LDL -0.11 mmol/L, all not significant.

Why this rating

Mixed: a small pooled benefit from few, short trials in people with diabetes, and a null longer trial in people at risk. The 2025 trial used enriched bread, not plain oats. It is an effectiveness trial with ties to oat and cereal companies.

Form and dose studied

Oat beta-glucan (Shen) and beta-glucan-enriched bread (Hjorth), not plain oatmeal.

Who was studied

Adults with type 2 diabetes (Shen); adults at risk of type 2 diabetes (Hjorth).

Limits

Only 4 articles (350 people) in the pooled analysis and no trials longer than 8 weeks in it. The 2025 trial is about bread. Oat intake was not compared with a placebo food in the same way across trials.

Why researchers looked

Beta-glucan is a viscous soluble fibre, so researchers asked whether it smooths blood sugar after meals and over time.

Traditional use

Traditional uses of oats are not described in the sources read, so none are described here. Long use as a food is not proof that it treats any condition.

Proposed mechanism Not described

Mechanism was not described in the abstracts read for this question.

A proposed mechanism does not show that the effect happens in people.

People with diabetes who take blood sugar medicines should ask their care team before changing their diet.

^{8 2}

After-meal blood sugar and how the oats are processed

Low certainty

In single-meal tests, intact oat kernels and thick oat flakes gave a smaller blood sugar and insulin rise than refined grain with the same carbohydrate. Thin, quick or instant oat flakes did not. This pooled analysis was done by authors linked to Quaker Oats and PepsiCo.

1 studiesIntact oat kernels, thick oat flakes and thin, quick or instant oat f…

Studies, doses and limits

What the trials found

Musa-Veloso 2021 pooled 10 publications of randomized test-meal studies: 3 comparisons of intact kernels, 7 of thick flakes (over 0.6 mm) and 6 of thin, quick or instant flakes, each against a refined grain with matched available carbohydrate.

Results

Smaller glucose and insulin rises with intact kernels and thick flakes, and no effect with thin, quick or instant flakes.

Effect sizes as reported

Intact kernels: glucose -45.5 mmol x min/L (95% CI -80.1 to -10.9), insulin -4.5 nmol x min/L (-7.1 to -1.8). Thick flakes: glucose -30.6 (-40.4 to -20.9), insulin -3.9 (-5.3 to -2.5). Thin, quick or instant flakes: no significant effect.

Why this rating

Low: single-meal tests against refined grain, only 3 kernel comparisons, and industry-linked authors. It says nothing about long-term blood sugar control.

Form and dose studied

Intact oat kernels, thick oat flakes and thin, quick or instant oat flakes as food. Note this is about after-meal blood sugar, not cholesterol.

Who was studied

Adults in test-meal trials (population details are not given in the abstract).

Limits

After-meal responses only. Compared with refined grain, not with other whole grains. Authors are affiliated with the Quaker Oats Center of Excellence, PepsiCo R&D Nutrition Sciences.

Why researchers looked

The form of the oat (whole kernel, thick flake or thin quick flake) may change how fast the starch is digested.

Traditional use

Traditional uses of oats are not described in the sources read, so none are described here. Long use as a food is not proof that it treats any condition.

Proposed mechanism Human trial meta analysis

The authors conclude that breaking up the structure of the oat kernel is likely linked to losing the glucose benefit.

A proposed mechanism does not show that the effect happens in people.

None specific.

⁶

Oat intake, type 2 diabetes, heart disease and early death (observational)

Low certainty

In 8 cohort studies (471,157 people), the highest oat intake went with 22% lower type 2 diabetes risk (RR 0.78). Links with heart disease, coronary heart disease and stroke were not statistically significant. One study found lower all-cause death. These are associations, not proof of cause.

1 studiesOats as food, measured in different ways across cohorts.

Studies, doses and limits

What the trials found

Wehrli 2021 pooled 9 articles from 8 prospective cohorts, comparing oat consumers with non-consumers and highest with lowest oat intake.

Results

Highest versus lowest oat intake: lower type 2 diabetes. No significant link with combined cardiovascular disease, coronary heart disease or stroke. All-cause death was lower in one study of three cohorts.

Effect sizes as reported

Type 2 diabetes, highest vs lowest RR 0.78 (95% CI 0.74 to 0.82); consumers vs non-consumers RR 0.86 (0.72 to 1.03, not significant). Coronary heart disease RR 0.81 (0.61 to 1.08); stroke RR 0.79 (0.59 to 1.07); combined cardiovascular disease RR 0.73 (0.5 to 1.07); all-cause death RR 0.76 (0.69 to 0.85) in men and 0.78 (0.70 to 0.87) in women.

Why this rating

Low: observational, no standard way of measuring oat intake, the mortality result rests on one study, and the analysis was supported by a supplement company (Standard Process), although the funder had no stated role in the analysis.

Form and dose studied

Oats as food, measured in different ways across cohorts.

Who was studied

Adults in 8 prospective cohorts.

Limits

Association only. Most studies were of fair to good quality. Oat intake is hard to separate from a healthy lifestyle.

Why researchers looked

People who eat more oats may differ in health, so researchers followed large groups over time.

Traditional use

Traditional uses of oats are not described in the sources read, so none are described here. Long use as a food is not proof that it treats any condition.

Proposed mechanism Observational

An association only; the abstract does not give a mechanism.

A proposed mechanism does not show that the effect happens in people.

None specific.

⁹

Whole grains and fibre in general (not oats alone)

Low certainty

Large pooled analyses of observational studies link more whole grain and more fibre with lower heart disease and earlier death risk, and trials of more fibre found lower body weight, blood pressure and total cholesterol. These findings are about whole grains and fibre as a group, and the abstracts do not report oats separately.

2 studiesWhole grains and fibre from many foods, not oats alone.

Studies, doses and limits

What the trials found

Aune 2016 pooled 45 prospective studies; Reynolds 2019 pooled 185 prospective studies and 58 trials (4,635 adults).

Results

Observational links with lower coronary heart disease, cardiovascular disease, cancer and all-cause death for whole grains, and similar findings for fibre; trials of higher fibre intake showed lower body weight, systolic blood pressure and total cholesterol.

Effect sizes as reported

Aune 2016, per 90 g a day more whole grain: coronary heart disease RR 0.81 (0.75 to 0.87); cardiovascular disease RR 0.78 (0.73 to 0.85); stroke RR 0.88 (0.75 to 1.03, not significant); all-cause death RR 0.83 (0.77 to 0.90). Reynolds 2019: 15 to 30% lower risk for several outcomes with higher fibre intake (observational).

Why this rating

Low for oats specifically: observational, and the abstracts do not report oats separately. Reynolds graded certainty moderate for dietary fibre and low to moderate for whole grains.

Form and dose studied

Whole grains and fibre from many foods, not oats alone.

Who was studied

Adults in prospective cohorts and fibre trials.

Limits

About whole grains as a group. People who eat whole grains may also exercise more and smoke less.

Why researchers looked

Oats are one whole-grain food among many, so whole-grain results are often used as context.

Traditional use

Traditional uses of oats are not described in the sources read, so none are described here. Long use as a food is not proof that it treats any condition.

Proposed mechanism Observational

Mechanisms were not described in the abstracts read.

A proposed mechanism does not show that the effect happens in people.

None specific.

^{1 7}

Avenanthramides (oat-specific compounds)

Not enough evidence

Avenanthramides are plant compounds found only in oats. Cell and animal studies suggest effects on inflammation and metabolism, but people absorb under 2% and no review found a proven avenanthramide-specific effect on weight, liver fat, insulin sensitivity or blood fats. Lab and animal findings, not shown to act in people.

2 studiesPurified avenanthramides, enriched foods and whole-oat products (as r…

Studies, doses and limits

What the trials found

Two 2026 narrative reviews. Human data show exposure to the compounds and metabolites; clinical evidence is mainly small studies of enriched foods in exercise settings.

Results

No avenanthramide-specific effect on adiposity, liver fat, insulin sensitivity, blood fats or other cardiometabolic outcomes was established in the studies reviewed.

Effect sizes as reported

Oral bioavailability under 2% in human studies (Mohammadi 2026). No effect sizes are given in the abstracts.

Why this rating

Insufficient: lab and animal evidence only, plus two narrative reviews that say human trials are needed.

Form and dose studied

Purified avenanthramides, enriched foods and whole-oat products (as reviewed). Not a dose or product claim.

Who was studied

Cells, animals and a few small human studies.

Limits

Narrative reviews, not systematic ones. Beta-glucan and other oat parts affect the same outcomes, so effects cannot be pinned on avenanthramides.

Why researchers looked

They are unique to oats, so researchers ask whether they add benefits beyond fibre.

Traditional use

Traditional uses of oats are not described in the sources read, so none are described here. Long use as a food is not proof that it treats any condition.

Proposed mechanism Lab animal

In cell and animal models they influence NF-kB-related inflammation, redox balance, liver insulin signalling and gut microbes. Reviews say most effects may be local in the gut and need confirming in people.

A proposed mechanism does not show that the effect happens in people.

None specific.

^{11 5}

Digestive health

Not enough evidence

Oats supply fibre, but no oat-specific trial on bowel regularity, gut symptoms or the gut microbiome was read for this page, so the evidence for oats is insufficient.

2 studiesNot applicable.

Studies, doses and limits

What the trials found

No oat-specific digestive trial was read. General fibre findings (Reynolds 2019) are about fibre from all foods.

Results

Nothing oat-specific to report.

Effect sizes as reported

No oat-specific numbers.

Why this rating

Insufficient: no oat-specific digestive outcomes were read.

Limits

A gap, not a negative finding.

Why researchers looked

Oats are a fibre-containing grain, and fibre is linked to bowel health in general.

Traditional use

Traditional uses of oats are not described in the sources read, so none are described here. Long use as a food is not proof that it treats any condition.

Proposed mechanism Not described

Not described in the sources read.

A proposed mechanism does not show that the effect happens in people.

A sudden rise in fibre can cause gas and bloating in some people (NIDDK describes this for undigested carbohydrates in general; oats are not named). See Safety.

^{7 16}

Connections to the rest of health

How Oats connects to the rest of our health knowledge graph. Every link says what kind of connection it is. A safety link (for example to the liver) is a warning, not a benefit. A study that merely mentions a topic never creates a benefit link.

Explore every connection: goals, body systems, organs, symptoms, genes

Kind of connection Connected to Search

A. Wellness goals

Connected to	Evidence status	Context	Studies
Preventive Wellness	High certainty	Fibre, protein and minerals (nutrient content): Oats cooked with water have 4.0 g of fibre, 5.9 g of protein, 63 mg of magnesium and 1.36 mg of manganese in a 234 g cup (USDA). Dry oats are much more concentrated. This is what the food contains, not a trial of a health effect.	^{17 18}
Cholesterol Balance	Moderate certainty	Cholesterol (oat beta-glucan): Two large pooled analyses of randomized trials found that oat beta-glucan, the soluble fibre in oats, lowered LDL ("bad") cholesterol a little: by 0.25 mmol/L in 28 trials and by 0.19 mmol/L in 58 trials. HDL cholesterol and triglycerides did not change significantly. This is a blood marker, not fewer heart attacks.	^{10 3 12}
Heart Health	Moderate certainty	Cholesterol (oat beta-glucan): Two large pooled analyses of randomized trials found that oat beta-glucan, the soluble fibre in oats, lowered LDL ("bad") cholesterol a little: by 0.25 mmol/L in 28 trials and by 0.19 mmol/L in 58 trials. HDL cholesterol and triglycerides did not change significantly. This is a blood marker, not fewer heart attacks.	^{10 3 12}
Blood Sugar Balance	Mixed findings	Blood sugar over weeks (type 2 diabetes and people at risk): Results are mixed. A 2016 pooled analysis of 4 short trials in 350 people with type 2 diabetes found oat beta-glucan lowered fasting glucose and HbA1c. A 2025 trial in 194 adults at risk of diabetes found beta-glucan-enriched bread did not change HbA1c, fasting glucose, insulin or LDL over 16 weeks. After-meal blood sugar and how the oats are processed: In single-meal tests, intact oat kernels and thick oat flakes gave a smaller blood sugar and insulin rise than refined grain with the same carbohydrate. Thin, quick or instant oat flakes did not. This pooled analysis was done by authors linked to Quaker Oats and PepsiCo.	^{8 2 6 9}
Heart Health	Low certainty	Oat intake, type 2 diabetes, heart disease and early death (observational): In 8 cohort studies (471,157 people), the highest oat intake went with 22% lower type 2 diabetes risk (RR 0.78). Links with heart disease, coronary heart disease and stroke were not statistically significant. One study found lower all-cause death. These are associations, not proof of cause. Whole grains and fibre in general (not oats alone): Large pooled analyses of observational studies link more whole grain and more fibre with lower heart disease and earlier death risk, and trials of more fibre found lower body weight, blood pressure and total cholesterol. These findings are about whole grains and fibre as a group, and the abstracts do not report oats separately.	^{9 1 7}
Preventive Wellness	Low certainty	Whole grains and fibre in general (not oats alone): Large pooled analyses of observational studies link more whole grain and more fibre with lower heart disease and earlier death risk, and trials of more fibre found lower body weight, blood pressure and total cholesterol. These findings are about whole grains and fibre as a group, and the abstracts do not report oats separately.	^{1 7}
Healthy Aging	Not enough evidence	Avenanthramides (oat-specific compounds): Avenanthramides are plant compounds found only in oats. Cell and animal studies suggest effects on inflammation and metabolism, but people absorb under 2% and no review found a proven avenanthramide-specific effect on weight, liver fat, insulin sensitivity or blood fats. Lab and animal findings, not shown to act in people.	^{11 5}
Digestive Support	Not enough evidence	Digestive health: Oats supply fibre, but no oat-specific trial on bowel regularity, gut symptoms or the gut microbiome was read for this page, so the evidence for oats is insufficient.	^{7 16}

B. Body systems

Connected to	Kind of connection	Evidence status	Context	Studies
Digestive System	Biological association	High certainty	Studied for: Fibre, protein and minerals (nutrient content) Studied for: Whole grains and fibre in general (not oats alone)	^{17 18 1 7 11 5 16}
Cardiovascular System	Biological association	Moderate certainty	Studied for: Cholesterol (oat beta-glucan) Studied for: Oat intake, type 2 diabetes, heart disease and early death (observational)	^{10 3 12 9 1 7}
Heart Circulation	Biological association	Moderate certainty	Studied for: Cholesterol (oat beta-glucan)	^{10 3 12}
Endocrine System	Biological association	Mixed findings	Studied for: Blood sugar over weeks (type 2 diabetes and people at risk) Studied for: After-meal blood sugar and how the oats are processed	^{8 2 6 9}

E. Health conditions

Connected to	Kind of connection	Evidence status	Context	Studies
Celiac disease	Adverse effect or risk	Documented risk	Oats can be contaminated with gluten; most people with celiac disease tolerate uncontaminated oats but a few do not. Preparation or compound: Oats with gluten cross-contact	^{15 4}
High cholesterol		Moderate certainty	Oat beta-glucan lowered LDL cholesterol a little in pooled trials; this is a blood marker. Preparation or compound: Oat beta-glucan in oat foods	^{10 3}

I. Biomarkers

Connected to	Kind of connection	Evidence status	Context	Studies
LDL cholesterol	Biological association	Moderate certainty	Measured in trials: lowered. A lab change is not the same as a health benefit.	^{10 3}
Total cholesterol	Biological association	Moderate certainty	Measured in trials: lowered. A lab change is not the same as a health benefit.	¹⁰
HDL cholesterol	Biological association	Moderate certainty	Measured in trials: no significant change. A lab change is not the same as a health benefit.	¹⁰
Triglycerides	Biological association	Moderate certainty	Measured in trials: no significant change. A lab change is not the same as a health benefit.	¹⁰
Non-HDL cholesterol and apolipoprotein B	Biological association	Low certainty	Measured in trials: lowered. A lab change is not the same as a health benefit.	³
Blood glucose (fasting and after meals)	Biological association	Mixed findings	Measured in trials: mixed. A lab change is not the same as a health benefit.	^{8 2 6}
HbA1c (average blood sugar over about 3 months)	Biological association	Mixed findings	Measured in trials: mixed. A lab change is not the same as a health benefit.	^{8 2}
Insulin (fasting and after meals)	Biological association	Low certainty	Measured in trials: mixed. A lab change is not the same as a health benefit.	^{8 2 6}

K. Biological pathways

Connected to	Kind of connection	Evidence status	Context	Studies
Dietary fibre (including beta-glucan)	Preliminary mechanism	Nutrient database	Dry oats have 10.1 g of fibre per 100 g and oats cooked with water have 1.7 g (USDA). Beta-glucan is not listed separately in those tables.	^{17 18}
LDL cholesterol	Preliminary mechanism	Human	Lowered a little by oat beta-glucan in pooled trials.	^{10 3}
Celiac disease	Preliminary mechanism	Human	Gluten cross-contact risk; a few people react to pure oats.	^{15 4}

L. Active compounds

Connected to	Kind of connection	Evidence status	Context	Studies
Mycotoxins (T-2 and HT-2)		Documented risk	WHO associates T-2 and HT-2 toxins with oats and advises discarding mouldy grain. Preparation or compound: Mould on damp or damaged grain	¹⁹
Oat beta-glucan	Biological association	Human	A viscous soluble fibre; in pooled trials oat beta-glucan lowered LDL cholesterol a little and in some trials fasting glucose and HbA1c. Preparation or compound: Grain, especially the bran	^{10 3 12}
Avenanthramides	Biological association	Lab	Cell and animal studies show effects on inflammation and metabolism. Human oral bioavailability is under 2%, and no avenanthramide-specific health effect has been established. Preparation or compound: Grain	^{11 5}
Starch	Biological association	Human	The main carbohydrate. How quickly it is digested may depend on how much the kernel has been broken up. Preparation or compound: Grain	^{17 18 6}
Protein	Biological association	Nutrient database	A nutrient amount; no effect was tested. Preparation or compound: Grain	^{17 18}
Total dietary fibre	Biological association	Nutrient database	Includes beta-glucan. Gut bacteria break down fibre that is not digested, which makes gas. Preparation or compound: Grain	^{17 18 16}
Manganese, magnesium, phosphorus and zinc	Biological association	Nutrient database	Nutrient amounts; absorption from oats was not read. Preparation or compound: Grain	^{17 18}

Each connection is stored with the ingredient, the connected record, the kind of connection, the evidence status, the supporting studies, the preparation or compound involved, and a review date (last reviewed October 26, 2026).

Evidence at a glance: what changed in 6 lab markers

Tap a number to show only those markers. Counts are markers, not people.

Metabolic23 Other1

The evidence

The research centre for Oats. Every record here was checked against PubMed or the publisher's page; we never list a study we have not verified.

Evidence by outcome

Fibre, protein and minerals (nutrient content) 2 studies High certainty Cholesterol (oat beta-glucan) 3 studies Moderate certainty Blood sugar over weeks (type 2 diabetes and people at risk) 2 studies Mixed findings After-meal blood sugar and how the oats are processed 1 study Low certainty Oat intake, type 2 diabetes, heart disease and early death (observational) 1 study Low certainty Whole grains and fibre in general (not oats alone) 2 studies Low certainty Avenanthramides (oat-specific compounds) 2 studies Not enough evidence Digestive health 2 studies Not enough evidence

Bars show how many studies we found for each outcome, not how well it works. People are added up across trials only (reviews are not added, to avoid double counting).

How we rate evidence

High certainty

Several well-run trials or reviews agree; further research is unlikely to change the picture much.

Moderate certainty

Good trials point the same way, but some doubt remains.

Low certainty

Small, short or inconsistent trials. The finding could change with better research.

Very low certainty

Very little or very weak human data. Treat as a possibility only.

Mixed findings

Trials or reviews disagree with each other.

Not enough evidence

Not enough human research to say either way.

Evidence against

Good research found no benefit, or found harm.

We take the reviewers' own risk-of-bias and GRADE statements where they exist, and otherwise judge from study size, design, consistency, directness and whether a product matches what is sold. Many publications do not make evidence high. Method note: We started from our existing oats summary, re-checked nutrition against USDA FoodData Central data, read the regulator and health agency pages (US CFR, FDA, NHS, WHO, NIDDK) and re-read PubMed abstracts for the pooled analyses, the trial and the cohort studies. Only abstracts were read for studies. A smaller set of studies is used on purpose: one source on the old page turned out to be a conference abstract and was replaced. Items we could not verify are flagged in the research gaps.

Study library: every study we checked 19

Design Research type Year from Search

Study	Design	People	Product, dose, length	Result
Aune 2016 Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies. BMJ · PMID 27301975 · DOI	Systematic review meta analysis	45 prospective studies (64 publications)	Whole grains in general (whole grain bread, breakfast cereals, added bran and others) Whole grains as eaten (oats are not reported separately in the abstract) Per 90 g a day more whole grain (about three servings) · vs Lower whole grain intake	Each 90 g a day more whole grain was linked to lower coronary heart disease, cardiovascular disease, total cancer death and all-cause death. The stroke link was not significant. The abstract does not report oats separately. Per 90 g a day: coronary heart disease RR 0.81; cardiovascular disease RR 0.78; stroke RR 0.88 (not significant); all-cause death RR 0.83 (CHD 0.75 to 0.87; CVD 0.73 to 0.85; stroke 0.75 to 1.03; all-cause death 0.77 to 0.90) Methods, limits and funding Outcomes: Coronary heart disease, stroke, cardiovascular disease, cancer and death Limitations: Observational, so it shows a link and not cause. About whole grains as a group; oats were not reported separately in the abstract. People who eat more whole grains may differ in other ways. Funding and conflicts: The conflict statement says the authors had no support from any organisation for the work and no relevant financial relationships. Read: abstract
Hjorth 2025 Effectiveness of regular oat β-glucan-enriched bread compared with whole-grain wheat bread on long-term glycemic control in adults at risk of type 2 diabetes: a randomized controlled trial. Am J Clin Nutr · PMID 40571100 · DOI	Randomized controlled trial	194 194 adults at risk of type 2 diabetes (average age 58, BMI 32, HbA1c 5.6%) at sites in Germany, Norway and Sweden	Bread enriched with oat beta-glucan (6 g beta-glucan a day) Oat beta-glucan added to bread (not plain oats) At least 3 slices a day, 6 days a week, giving 6 g beta-glucan a day 16 weeks · vs Whole-grain wheat bread	No significant difference between the beta-glucan bread and whole-grain wheat bread for HbA1c, fasting glucose, insulin or LDL cholesterol. The authors say the trial does not support metabolic benefits of beta-glucan-enriched bread in real-life conditions. HbA1c difference -0.01%; fasting glucose -0.02 mmol/L; insulin -0.76 pmol/L; LDL -0.11 mmol/L (all not significant) (HbA1c -0.03 to 0.06 (P = 0.49); fasting glucose -0.11 to 0.14; insulin -0.99 to 2.5; LDL -0.27 to 0.05) Methods, limits and funding Outcomes: HbA1c, fasting glucose, insulin and LDL cholesterol Limitations: Studied bread enriched with beta-glucan, not plain oats, in people at risk of diabetes (not people with diabetes). Compared with whole-grain wheat bread, not with a refined control. Funding and conflicts: Public research funding (German federal ministry and the Research Council of Norway). The conflict statement also lists relationships of some authors with Lantmannen Research Foundation, Oatly, Barilla and Arla Food and Health, and says Lantmannen Cerealia AB provided equipment or supplies. Registration: NCT04994327 Read: abstract
Ho 2016 The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials. Br J Nutr · PMID 27724985 · DOI	Systematic review meta analysis	3974 58 randomised trials (3,974 people) of at least 3 weeks	Diets enriched with oat beta-glucan compared with control diets Oat beta-glucan (oat grain fibre) Median 3.5 g a day of oat beta-glucan At least 3 weeks · vs Control diets	Oat beta-glucan lowered LDL cholesterol, non-HDL cholesterol and apoB compared with control. There was considerable unexplained difference between trials for LDL (I2 79%) and non-HDL cholesterol (I2 99%). LDL -0.19 mmol/L; non-HDL -0.20 mmol/L; apoB -0.03 g/L (all P < 0.0001) (LDL -0.23 to -0.14 mmol/L; non-HDL -0.26 to -0.15 mmol/L; apoB -0.05 to -0.02 g/L) Methods, limits and funding Outcomes: LDL cholesterol, non-HDL cholesterol and apolipoprotein B Limitations: Large unexplained differences between trials (I2 79% for LDL, 99% for non-HDL). Blood markers, not heart attacks or strokes. Includes oat-enriched foods, so the exact food differs by trial. Funding and conflicts: Funding is not stated in the abstract. Read: abstract
La Vieille 2016 Celiac Disease and Gluten-Free Oats: A Canadian Position Based on a Literature Review. Can J Gastroenterol Hepatol · PMID 27446825 · DOI	Narrative literature review	Literature review of studies published January 2008 to January 2015 on uncontaminated oats (under 20 ppm gluten) in people with celiac disease	Oats uncontaminated by wheat, rye and barley (under 20 ppm gluten) Oats as food The review found no conclusive evidence for a specific daily limit	The review concluded that oats uncontaminated by gluten-containing cereals can be safely eaten by most people with celiac disease, while a few seem clinically intolerant to oats. It advises a stabilization phase: uncontaminated oats should be introduced only after symptoms have resolved and the person has been on a gluten-free diet for at least 6 months, with long-term medical follow-up. No numbers in the abstract beyond the 20 ppm and 6-month thresholds (Not applicable) Methods, limits and funding Outcomes: Safety of uncontaminated oats in celiac disease Limitations: A review of the literature by Health Canada authors, not a trial. It updates a 2007 Health Canada position. Published 2016 (studies to 2015). Funding and conflicts: Funding is not stated in the abstract. The authors are affiliated with the Food Directorate of Health Canada, a regulator. Read: abstract
Mohammadi 2026 Avenanthramides as digestion-stage modulators: Mechanistic links across the gastrointestinal continuum. Food Chem X · PMID 42712909 · DOI	Narrative review human, animal and cell studies (narrative review)	Review of what happens to oat avenanthramides during digestion	Avenanthramides, oat-specific phenolic compounds Oat-specific compounds	Human studies consistently report very low oral bioavailability (under 2%). The review proposes that avenanthramides act mainly through local effects in the gut (for example on starch breakdown and glucose transport), and says the proposed pathways need confirmation in well-designed human studies. Oral bioavailability under 2% (human studies, as summarised by the authors) (Not applicable) Methods, limits and funding Outcomes: Bioavailability and digestion-stage mechanisms Limitations: A conceptual review. Its proposed mechanisms are not shown in people. Funding and conflicts: The authors declare a government (Irish agriculture department) funding source and no competing interests. Read: abstract
Musa-Veloso 2021 A Systematic Review and Meta-Analysis of Randomized Controlled Trials on the Effects of Oats and Oat Processing on Postprandial Blood Glucose and Insulin Responses. J Nutr · PMID 33296453 · DOI	Systematic review meta analysis	10 publications of randomized trials of test meals; oats compared with a refined grain with similar available carbohydrate	Intact oat kernels, thick oat flakes (more than 0.6 mm) and thin, quick or instant oat flakes (0.6 mm or less) Oat kernels and flakes as food Test meals matched for available carbohydrate Single meals (after-meal blood tests) · vs Refined grain	Intact oat kernels and thick oat flakes lowered the after-meal glucose and insulin response compared with refined grain. Thin, quick or instant oat flakes did not. The authors conclude that breaking up the structure of the oat kernel is likely linked to losing the glucose benefit. Intact kernels: glucose -45.5 mmol x min/L (P = 0.010), insulin -4.5 nmol x min/L (P = 0.001); thick flakes: glucose -30.6 mmol x min/L (P < 0.001), insulin -3.9 nmol x min/L (P < 0.001); thin, quick or instant flakes: no effect (Kernels: glucose -80.1 to -10.9, insulin -7.1 to -1.8; thick flakes: glucose -40.4 to -20.9, insulin -5.3 to -2.5) Methods, limits and funding Outcomes: After-meal blood glucose and insulin (incremental area under the curve) Limitations: Single-meal tests, not long-term blood sugar control. Only 3 comparisons used intact kernels. Compared with refined grain, not with other whole grains. Funding and conflicts: Industry-linked: authors are affiliated with the Quaker Oats Center of Excellence, PepsiCo R&D Nutrition Sciences, and with a consulting firm (Intertek Health Sciences). Read: abstract
Reynolds 2019 Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet · PMID 30638909 · DOI	Systematic review meta analysis	185 prospective studies and 58 clinical trials (4,635 adults) of dietary fibre, whole grains and glycaemic index	Dietary fibre and whole grains in general Fibre and whole grains as eaten (oats not reported separately in the abstract) Risk reduction was greatest at 25 g to 29 g of fibre a day (all foods) Observational and trial data · vs Lower fibre or whole grain intake	Higher fibre intake was linked to 15 to 30% lower all-cause and cardiovascular death and lower incidence of several diseases (observational), and trials found lower body weight, systolic blood pressure and total cholesterol with more fibre. The authors say similar findings were seen for whole grains. They graded certainty moderate for dietary fibre and low to moderate for whole grains. Observational: 15 to 30% lower risk (highest vs lowest fibre intake); trials: lower body weight, systolic blood pressure and total cholesterol (Not given as a single figure in the abstract) Methods, limits and funding Outcomes: Death, coronary heart disease, stroke, type 2 diabetes, colorectal cancer, body weight, blood pressure and cholesterol Limitations: General fibre and whole grain findings, not oats. Excluded trials of supplements, weight loss and people with chronic disease. The abstract does not name oats. Funding and conflicts: Funding is not stated in the abstract (the record lists non-US government research support). Read: abstract
Shen 2016 Effect of Oat β-Glucan Intake on Glycaemic Control and Insulin Sensitivity of Diabetic Patients: A Meta-Analysis of Randomized Controlled Trials. Nutrients · PMID 26771637 · DOI	Systematic review meta analysis	350 4 articles, 350 people with type 2 diabetes	Oat beta-glucan (2.5 to 3.5 g a day) compared with control Oat beta-glucan 2.5 to 3.5 g a day of oat beta-glucan 3 to 8 weeks · vs Control	Oat beta-glucan lowered fasting glucose and HbA1c in people with type 2 diabetes, but did not significantly lower fasting insulin. The authors note that data on long-term intake are scarce. Fasting plasma glucose -0.52 mmol/L (P = 0.01); HbA1c -0.21% (P = 0.03); fasting insulin not significant (Fasting glucose -0.94 to -0.10 mmol/L; HbA1c -0.40 to -0.02%) Methods, limits and funding Outcomes: Fasting plasma glucose, HbA1c and fasting insulin Limitations: Only four articles and 350 people; trials of 3 to 8 weeks only; the abstract does not say whether the beta-glucan came from oat foods or concentrates. Published 2016, so later trials are not included. Funding and conflicts: Funding is not stated in the abstract (the record lists non-US government research support). Read: abstract
Wehrli 2021 Oat Intake and Risk of Type 2 Diabetes, Cardiovascular Disease and All-Cause Mortality: A Systematic Review and Meta-Analysis. Nutrients · PMID 34444718 · DOI	Systematic review meta analysis	471157 9 articles from 8 prospective cohort studies, 471,157 people	Oats eaten as food (oat consumers versus non-consumers, and highest versus lowest oat intake) Oats as eaten · vs Lower or no oat intake	Highest oat intake was linked to lower type 2 diabetes (RR 0.78). Oat consumers versus non-consumers did not differ significantly for type 2 diabetes, and no significant link was found with combined cardiovascular disease, coronary heart disease or stroke. One study of three cohorts found lower all-cause death (RR 0.76 men, 0.78 women). Type 2 diabetes, highest vs lowest intake RR 0.78; consumers vs non-consumers RR 0.86 (not significant); CHD RR 0.81 (not significant); stroke RR 0.79 (not significant); combined CVD RR 0.73 (not significant); all-cause death RR 0.76 (men) and 0.78 (women), one study (T2D highest vs lowest 0.74 to 0.82; consumers vs non-consumers 0.72 to 1.03; CHD 0.61 to 1.08; stroke 0.59 to 1.07; CVD 0.5 to 1.07; mortality 0.69 to 0.85 (men), 0.70 to 0.87 (women)) Methods, limits and funding Outcomes: Type 2 diabetes, cardiovascular disease, coronary heart disease, stroke and all-cause death Limitations: Observational, so it shows a link and not cause. The authors say standard ways of measuring oat intake and oat product type are lacking. The mortality result rests on one study. Funding and conflicts: Industry-linked: the conflict statement says the work was supported by Standard Process, a whole-food supplement company, which paid some authors and the publication fee; it says the company had no role in design, analysis or the decision to publish. Read: abstract
Whitehead 2014 Cholesterol-lowering effects of oat β-glucan: a meta-analysis of randomized controlled trials. Am J Clin Nutr · PMID 25411276 · DOI	Systematic review meta analysis	28 randomized controlled trials comparing oat beta-glucan with a control diet	Oat beta-glucan (3 g a day or more) in oat foods and oat products Oat beta-glucan (oat grain fibre) 3.0 to 12.4 g a day of oat beta-glucan across trials 2 to 12 weeks · vs Appropriate control diet	Oat beta-glucan lowered LDL and total cholesterol compared with control, with no significant effect on HDL cholesterol or triglycerides. The LDL fall was larger when starting LDL was higher, and larger in people with diabetes (few studies). LDL cholesterol -0.25 mmol/L (P < 0.0001); total cholesterol -0.30 mmol/L (P < 0.0001); no significant effect on HDL or triglycerides (LDL 0.20 to 0.30 mmol/L lower; total cholesterol 0.24 to 0.35 mmol/L lower) Methods, limits and funding Outcomes: LDL, total, HDL cholesterol and triglycerides Limitations: Short trials (2 to 12 weeks) measuring a blood marker, not heart attacks or strokes. Some heterogeneity (P = 0.13 for LDL). Searches were in three databases plus in-house study reports from a company (CreaNutrition AG), so unpublished company data may be included. Funding and conflicts: Funding is not stated in the abstract. The abstract says in-house study reports from CreaNutrition AG were searched in addition to databases. Read: abstract
Zhang 2026 Avenanthramides in Obesity-Related Metabolic Dysfunction: Mechanisms, Evidence Attribution, and Translational Priorities. Nutrients · PMID 42797048 · DOI	Narrative review human, animal and cell studies (narrative review)	Narrative review of cell, animal, pharmacokinetic and human studies of avenanthramides (oat-specific phenolic amides)	Avenanthramides (purified compounds, enriched foods and whole-oat products) Oat-specific compounds	In cell and animal models avenanthramides influence inflammation, redox balance, liver insulin signalling, glucose production, fat metabolism and gut ecology. Human studies show dietary exposure to the compounds and their metabolites, but clinical evidence comes mainly from small exercise studies of enriched foods. Among the studies reviewed, none showed an avenanthramide-specific effect on adiposity, liver fat, insulin sensitivity, blood fats or other cardiometabolic outcomes. No numbers in the abstract (Not applicable) Methods, limits and funding Outcomes: Mechanisms and clinical outcomes (adiposity, liver fat, insulin sensitivity, blood fats) Limitations: A narrative review (not a systematic one). Mostly cell and animal work. It says beta-glucan and the wider oat matrix can affect the same outcomes, so effects cannot be pinned on avenanthramides. Funding and conflicts: The authors declare no conflicts of interest. Read: abstract
s-cfr-101-81 US Code of Federal Regulations, 21 CFR 101.81: Health claims: soluble fiber from certain foods and risk of coronary heart disease (text shown by Cornell Legal Information Institute) · Source	Regulation n/a			Methods, limits and funding Read: full-text
s-fda-gluten-free US FDA: Questions and Answers on the Gluten-Free Labeling of Foods · Source	Regulator guidance n/a			Methods, limits and funding Read: full-text
s-gbif-avena-sativa GBIF Backbone Taxonomy: Avena sativa L. (usageKey 2705290) · Source	Reference database n/a			Methods, limits and funding Read: full-text
s-nhs-coeliac NHS (UK): Coeliac disease · Source	Health agency n/a			Methods, limits and funding Read: full-text
s-niddk-gas NIDDK (US National Institutes of Health): Symptoms and Causes of Gas in the Digestive Tract · Source	Health agency n/a			Methods, limits and funding Read: full-text
s-usda-fdc-173904 USDA FoodData Central: Cereals, oats, regular and quick, not fortified, dry (FDC 173904, SR Legacy, April 2018 release; item last updated 4/1/2019) · Source	Reference database n/a			Methods, limits and funding Read: full-text
s-usda-fdc-173905 USDA FoodData Central: Cereals, oats, regular and quick, unenriched, cooked with water (includes boiling and microwaving), without salt (FDC 173905, SR Legacy; item last updated 4/1/2019) · Source	Reference database n/a			Methods, limits and funding Read: full-text
s-who-mycotoxins WHO fact sheet: Mycotoxins (2 October 2023) · Source	Health agency n/a			Methods, limits and funding Read: full-text

What we do not know yet

No trial comparing instant, rolled and steel-cut oats for cholesterol was found, and the cholesterol trials measured blood markers rather than heart attacks or strokes.
The longer blood sugar trial used beta-glucan-enriched bread, not plain oats; no long-term trial of plain oatmeal on HbA1c was read.
The whole-grain and heart disease results are observational and do not report oats separately.
Oat allergy, pregnancy, breastfeeding, children, kidney disease, heavy metals, pesticide residues, acrylamide and levels of mould toxins in oat products were not researched.
Several analyses have industry ties: authors linked to Quaker Oats and PepsiCo (after-meal tests), a supplement company (cohort analysis), and oat or cereal companies (a 2025 trial).

How new research is added

New studies are found by a saved PubMed search and placed in a review queue before the page changes.

Lab markers

What changed in blood or saliva tests during trials. A changed number is not the same as feeling or being healthier, and we give no "normal ranges".

Metabolic 7

▼

LDL cholesterol

Lowered in trials

The 'bad' cholesterol carried in the blood. Higher levels are linked to more heart disease.

Moderate certainty

Results and what it means

Why it was measured

It is the usual blood marker used in diet trials for heart risk.

Statistical vs. clinical meaning

A small average fall in short trials, with wide differences between trials.

Safety implication

None specific.

Study	Result	People	Product
¹⁰	LDL -0.25 mmol/L (95% CI -0.30 to -0.20) versus control	28 randomized trials; greater fall with higher starting LDL	Oat beta-glucan, 3 g a day or more (range 3.0 to 12.4 g), 2 to 12 weeks
³	LDL -0.19 mmol/L (95% CI -0.23 to -0.14) versus control; I2 79%	58 randomized trials, 3,974 people	Oat beta-glucan, median 3.5 g a day, at least 3 weeks

^{10 3}

▼

Total cholesterol

Lowered in trials

All the cholesterol carried in the blood, "good" and "bad" together.

Moderate certainty

Results and what it means

Why it was measured

It is a basic blood marker used in diet trials.

Statistical vs. clinical meaning

A small fall in short trials.

Safety implication

None specific.

Study	Result	People	Product
¹⁰	Total cholesterol -0.30 mmol/L (95% CI -0.35 to -0.24) versus control	28 randomized trials	Oat beta-glucan, 3 g a day or more, 2 to 12 weeks

¹⁰

●

HDL cholesterol

No significant change in trials

The 'good' cholesterol carried in the blood.

Moderate certainty

Results and what it means

Why it was measured

To see whether oat beta-glucan changes the protective fraction.

Statistical vs. clinical meaning

No clear change, which is a finding in itself.

Safety implication

None specific.

Study	Result	People	Product
¹⁰	No significant effect of oat beta-glucan on HDL cholesterol	28 randomized trials	Oat beta-glucan, 3 g a day or more, 2 to 12 weeks

¹⁰

●

Triglycerides

No significant change in trials

Fats carried in the blood after a meal and between meals.

Moderate certainty

Results and what it means

Why it was measured

High levels are linked to heart risk.

Statistical vs. clinical meaning

No clear change.

Safety implication

None specific.

Study	Result	People	Product
¹⁰	No significant effect of oat beta-glucan on triglycerides	28 randomized trials	Oat beta-glucan, 3 g a day or more, 2 to 12 weeks

¹⁰

↕

Blood glucose (fasting and after meals)

Mixed results in trials

The sugar level in the blood, measured after fasting or after a test meal.

Mixed findings

Results and what it means

Why it was measured

To see whether oats change blood sugar.

Statistical vs. clinical meaning

Small drops in short trials and single meals; none in a 16-week trial.

Safety implication

People who take blood sugar medicines should ask their care team before changing their diet.

Study	Result	People	Product
⁸	Fasting plasma glucose -0.52 mmol/L (95% CI -0.94 to -0.10)	4 articles, 350 people with type 2 diabetes	Oat beta-glucan, 2.5 to 3.5 g a day, 3 to 8 weeks
²	Fasting glucose -0.02 mmol/L (95% CI -0.11 to 0.14), not significant	194 adults at risk of type 2 diabetes	Beta-glucan-enriched bread, 6 g beta-glucan a day, 16 weeks
⁶	After-meal glucose response lower with intact kernels (-45.5 mmol x min/L) and thick flakes (-30.6), no effect with thin, quick or instant flakes	10 publications of test-meal trials	Oat kernels and flakes versus refined grain

^{8 2 6}

↕

HbA1c (average blood sugar over about 3 months)

Mixed results in trials

A blood test that reflects average blood sugar over the past two to three months.

Mixed findings

Results and what it means

Why it was measured

It is the main long-term marker of diabetes control.

Statistical vs. clinical meaning

A small drop in few short trials and no change in a 16-week trial.

Safety implication

None specific.

Study	Result	People	Product
⁸	HbA1c -0.21% (95% CI -0.40 to -0.02)	4 articles, 350 people with type 2 diabetes	Oat beta-glucan, 2.5 to 3.5 g a day, 3 to 8 weeks
²	HbA1c -0.01% (95% CI -0.03 to 0.06), not significant	194 adults at risk of type 2 diabetes	Beta-glucan-enriched bread, 6 g beta-glucan a day, 16 weeks

^{8 2}

↕

Insulin (fasting and after meals)

Mixed results in trials

The hormone that moves sugar from the blood into cells.

Low certainty

Results and what it means

Why it was measured

To see whether oats change how much insulin the body needs.

Statistical vs. clinical meaning

Lower after-meal insulin with less-processed oats in industry-linked single-meal tests; no fasting change.

Safety implication

None specific.

Study	Result	People	Product
⁸	Fasting insulin not significantly lowered	4 articles, 350 people with type 2 diabetes	Oat beta-glucan, 2.5 to 3.5 g a day, 3 to 8 weeks
²	Insulin -0.76 pmol/L (95% CI -0.99 to 2.5), not significant	194 adults at risk of type 2 diabetes	Beta-glucan-enriched bread, 16 weeks
⁶	After-meal insulin response lower with intact kernels (-4.5 nmol x min/L) and thick flakes (-3.9), no effect with thin, quick or instant flakes	10 publications of test-meal trials	Oat kernels and flakes versus refined grain

^{8 2 6}

Other 1

▼

Non-HDL cholesterol and apolipoprotein B

Lowered in trials

Non-HDL cholesterol is all cholesterol except the "good" kind. ApoB is a protein found on the particles that carry "bad" cholesterol.

Low certainty

Results and what it means

Why it was measured

They are other blood markers of heart risk, used beside LDL.

Statistical vs. clinical meaning

Lowered on average, but the trials differed enormously for non-HDL (I2 99%), so the size of the effect is uncertain.

Safety implication

None specific.

Study	Result	People	Product
³	Non-HDL cholesterol -0.20 mmol/L (95% CI -0.26 to -0.15; I2 99%); apoB -0.03 g/L (95% CI -0.05 to -0.02)	58 randomized trials, 3,974 people	Oat beta-glucan, median 3.5 g a day, at least 3 weeks

Safety

What studies and official sources say about side effects, medicines and who should check first. Each point shows what kind of evidence it comes from.

Main points to know 3

Cross-contact with gluten: a real problem for people with celiac disease. Oats do not contain gluten, but the NHS says they can cause a reaction if produced in the same place as wheat, barley and rye, and that a small number of people with coeliac disease may also get symptoms from pure oats. A Health Canada literature review concluded that oats not contaminated by gluten-containing grains can be safely eaten by most people with celiac disease, while a few seem clinically intolerant to oats. In the US, oats labelled gluten-free must contain less than 20 ppm gluten. If you have celiac disease, ask your clinician or dietitian before adding oats. Authoritative guidance ^{15 4 13}
Mould toxins can grow on damp or damaged grain. WHO says mycotoxins are made by moulds and can be found in cereals, often under warm and humid conditions, and names T-2 and HT-2 toxins (from Fusarium moulds) as associated with oats. WHO advice includes keeping grain dry and not too warm, buying it as fresh as possible, and discarding food that looks mouldy. Authoritative guidance ¹⁹
Sudden extra fibre can cause gas and bloating. NIDDK explains that carbohydrates, including fibre, that the stomach and small intestine do not fully digest are broken down by gut bacteria, which makes gas. This is a general statement about fibre; oats are not named on the page. Authoritative guidance ¹⁶

Side effects 2

Effect	How often	Severity and recovery	Evidence
Symptoms of celiac disease after eating oats contaminated with gluten, or (in a small number of people) after pure oats The risk is mainly from cross-contact with wheat, barley or rye during growing, milling or packing.	NHS: "a small number" of people with coeliac disease may react to pure oats. Health Canada review: "a few" people seem clinically intolerant to oats. No percentages are given in the abstract or page text read.	Not described in the sources read. Not described in the sources read.	Authoritative guidance ^{15 4}
Gas, bloating and abdominal discomfort NIDDK describes this for undigested carbohydrates in general. It does not name oats.	No frequency for oats was found.	Not described for oats. Not described for oats.	Authoritative guidance ¹⁶

Liver

No liver injury from eating oats was found in the sources read. A liver-safety source (such as LiverTox) was not searched for oats.

How often. No frequency was found.

Monitoring. No agency monitoring advice was found.

This is a safety connection. It is not evidence that Oats supports liver health.

Medicines and supplements 2

With	Why it matters	Importance	Evidence	What to do
Cholesterol-lowering medicines (for example statins) prescription	Not described in the sources read. The cholesterol trials of oat beta-glucan were pooled analyses of diets and did not report on medicine interactions in the abstracts read.	No interaction between oats and any medicine was found in the sources read. This is an absence of information, not proof that there is none.	None found Not enough evidence ¹⁰	If you take cholesterol or diabetes medicines, ask your prescriber or pharmacist before making big changes to your diet.
Blood sugar medicines (for people with diabetes) prescription	Not described in the sources read. Oat beta-glucan lowered fasting glucose and HbA1c a little in short trials in type 2 diabetes, so a diet change could matter for people on blood-sugar medicines.	No interaction report for oats was found. The point is about blood sugar changing, not a documented drug interaction.	None found Not enough evidence ⁸	Ask your care team before changing your diet if you take blood-sugar medicines.

Who should check first 4

Situation	Advice	Evidence
Celiac disease or another gluten-related condition	Ask your clinician or dietitian before adding oats. Use oats labelled gluten-free (under 20 ppm in the US). The Health Canada review advises introducing uncontaminated oats only after symptoms have settled and a gluten-free diet has been followed for at least 6 months, with regular medical follow-up.	Authoritative guidance ^{4 13 15}
Oats that look or smell mouldy, or have been stored damp	Throw them away. WHO advises discarding food that looks mouldy and keeping grain dry and not too warm.	Authoritative guidance ¹⁹
Pregnancy and breastfeeding	No official statement about oats as a food in pregnancy or breastfeeding was found in the sources read. Ask your midwife or doctor about your own diet.	None found
Babies and young children	No oat-specific advice for infants or children was read, including on choking or allergy. Ask your paediatrician or health visitor.	None found

Overdose, product quality and regulators

Summary. No toxicity from oats eaten as ordinary food was found in the sources read. The safety points are gluten cross-contact for people with celiac disease, mould toxins in badly stored grain and gas from extra fibre.

Animal. Not reviewed.

High dose or long term signals. Not found. Trials of oat beta-glucan lasted from 2 to 16 weeks and the abstracts read did not report serious harms.

Overdose response. Not found.

Genotoxicity. Not researched.

Two contamination points were read: gluten from cross-contact and mould toxins. Heavy metals, pesticide residues (including glyphosate) and acrylamide in oat products were not researched.

Gluten cross-contact. NHS: oats can cause a reaction if produced alongside wheat, barley and rye. FDA: oats labelled "gluten-free" must contain less than 20 ppm gluten; oats do not need third-party certification to be labelled this way, and the claim is voluntary. ^{15 13}

Mould toxins (T-2 and HT-2). WHO names T-2 and HT-2 toxins as associated with oats, warns that trichothecenes can be acutely toxic to humans and cause irritation and diarrhoea, and gives storage advice. It gives no figures for oat products. ¹⁹

Body	Action	Date
US FDA (21 CFR 101.81) (United States)	Health claim rule: diets low in saturated fat and cholesterol that include soluble fiber from certain foods may reduce the risk of heart disease. It names 3 g or more per day of beta-glucan soluble fiber from whole oats or barley as the associated level and lists eligible forms: oat bran, rolled oats and whole oat flour. This is a labelling rule, not a personal recommendation. source	2023-03-24
US FDA (gluten-free labelling) (United States)	Oats labelled "gluten-free" must contain less than 20 ppm gluten; certification is not required. The claim is voluntary. source	2022-06-30
NHS (UK) (United Kingdom)	Coeliac disease page: oats do not contain gluten but can cause an adverse reaction if produced in the same place as wheat, barley and rye; a small number of people with coeliac disease may react to pure oats. source	2023-03-31
WHO (International)	Mycotoxins fact sheet: T-2 and HT-2 toxins are associated with oats; advice includes storing grain dry and discarding mouldy food. source	2023-10-02
Health Canada (literature review) (Canada)	Position paper by Health Canada authors, updating the 2007 Health Canada position: oats uncontaminated by gluten-containing cereals can be safely eaten by most people with celiac disease, a few are intolerant, and a 6-month stabilization phase is advised first. source	2016-02-24

When to get medical help

Trouble breathing, wheezing, swelling of the lips, face, tongue or throat, widespread hives or collapse soon after eating oats or any food (possible severe allergic reaction): use epinephrine if prescribed, then call 911 or your local emergency number. Oat allergy was not researched for this page, but this advice holds for any food.
Repeated vomiting, severe diarrhoea or blood in the stool after eating oats or any grain that looked or smelled mouldy: seek medical care.

Stop using the product and contact a clinician or emergency service. In the US, Poison Control is 1-800-222-1222.

General information only, not medical advice. Ask a clinician or pharmacist before use, especially with medicines, in pregnancy or with a health condition. See the Natural Remedy Safety guide.

Frequently asked questions

What are oats?

Oats are the grain of the oat plant (Avena sativa), eaten as a whole grain. The edible part is called the groat. Rolled oats, quick oats, oat bran and whole oat flour are different ways of preparing it.

^{14 12}

Do oats lower cholesterol?

A little, on average. In a pooled analysis of 28 randomized trials, oat beta-glucan lowered LDL cholesterol by 0.25 mmol/L, and a later review of 58 trials found 0.19 mmol/L, with big differences between trials. That is a change in a blood marker, not proof of fewer heart attacks.

^{10 3}

Can oats prevent heart disease?

This was not shown. The cholesterol trials measured a blood marker. A pooled analysis of 8 cohort studies found no statistically significant link between oat intake and cardiovascular disease, and cohort studies cannot show cause.

^{10 9}

What does the US heart-health label on oats mean?

It is a labelling rule. US regulations allow a claim that diets low in saturated fat and cholesterol that include beta-glucan soluble fibre from whole oats or barley may reduce the risk of heart disease, and list oat bran, rolled oats and whole oat flour as eligible forms. It is not a personal recommendation.

¹²

Do oats help with blood sugar or diabetes?

The evidence is mixed. Short trials in people with type 2 diabetes found small drops in fasting glucose and HbA1c with oat beta-glucan, but a 16-week trial in adults at risk of diabetes found no change with beta-glucan-enriched bread. Cohort studies link higher oat intake with lower type 2 diabetes risk, which cannot prove cause. Ask your care team if you take diabetes medicine.

^{8 2 9}

Does it matter which kind of oats I choose?

For after-meal blood sugar, a pooled analysis of test meals found intact kernels and thick flakes lowered the glucose and insulin rise but thin, quick or instant flakes did not (authors linked to Quaker Oats and PepsiCo). No source read compared instant, rolled and steel-cut oats for cholesterol. Flavoured packets may have added sugar, so check the label.

⁶

Are oats gluten-free?

Oats themselves do not contain gluten, but the NHS says they can cause a reaction if produced in the same place as wheat, barley and rye. In the US, oats labelled "gluten-free" must contain less than 20 ppm gluten.

^{15 13}

Can I eat oats if I have celiac disease?

Ask your clinician or dietitian first. A Health Canada review concluded that oats not contaminated with wheat, rye or barley can be safely eaten by most people with celiac disease, while a few seem intolerant to oats, and it advises waiting until symptoms have settled and a gluten-free diet has been followed for at least 6 months.

^{4 15}

Are oats safe to eat if they have been stored damp?

No. WHO says moulds on cereals can produce toxins, names T-2 and HT-2 toxins as associated with oats, and advises keeping grain dry and not too warm and throwing away mouldy food.

¹⁹

Can oats cause gas or bloating?

They might in some people. NIDDK explains that fibre and other carbohydrates the small intestine does not fully digest are broken down by gut bacteria, which makes gas. That is a general statement; oats are not named on the page.

¹⁶

Do oats interact with medicines?

No interaction between oats and any medicine was found in the sources read. That is an absence of information, not proof of safety. If you take cholesterol or blood sugar medicines, ask your prescriber or pharmacist before big diet changes.

^{10 8}

Are oats the same as oat milk, oat bran or oatmeal baths?

No. Oat milk and oat bran have their own pages, and oatmeal in baths or skin products is a different topic. Results for oats as a food do not automatically apply to them.

¹²

Explore by health goal

Heart Health Blood Sugar Balance Preventive Wellness Cholesterol Balance Healthy Aging Digestive Support

Editorial transparency

Written by: AlternativeMed editorial team. Research compiled with AI assistance, then checked against the sources listed.
Medical review: None. This page has not been reviewed by a physician or pharmacist.
First published: 2026-10-26
Last substantive update: 2026-10-26
How we research: We started from our existing oats summary, re-checked nutrition against USDA FoodData Central data, read the regulator and health agency pages (US CFR, FDA, NHS, WHO, NIDDK) and re-read PubMed abstracts for the pooled analyses, the trial and the cohort studies. Only abstracts were read for studies. A smaller set of studies is used on purpose: one source on the old page turned out to be a conference abstract and was replaced. Items we could not verify are flagged in the research gaps.
How we rate evidence: See "How we rate evidence" in the Evidence tab.
Independence: No product is promoted on this page. No affiliate links are shown. Industry links are stated where a study is used: authors of the after-meal analysis are linked to Quaker Oats and PepsiCo, the cohort analysis was supported by a supplement company, and some authors of the 2025 trial report ties to oat and cereal companies.

Sources 19

Each source was opened and checked. Where we read only the abstract, it says so. The small numbers in the text point here.

Aune D, Keum N, Giovannucci E, Fadnes LT, et al.. Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies.. BMJ. 2016. PMID 27301975. DOI 10.1136/bmj.i2716. (abstract)
Hjorth T, Schadow A, Revheim I, Spielau U, et al.. Effectiveness of regular oat β-glucan-enriched bread compared with whole-grain wheat bread on long-term glycemic control in adults at risk of type 2 diabetes: a randomized controlled trial.. Am J Clin Nutr. 2025. PMID 40571100. DOI 10.1016/j.ajcnut.2025.06.018. (abstract)
Ho HV, Sievenpiper JL, Zurbau A, Blanco Mejia S, et al.. The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials.. Br J Nutr. 2016. PMID 27724985. DOI 10.1017/S000711451600341X. (abstract)
La Vieille S, Pulido OM, Abbott M, Koerner TB, et al.. Celiac Disease and Gluten-Free Oats: A Canadian Position Based on a Literature Review.. Can J Gastroenterol Hepatol. 2016. PMID 27446825. DOI 10.1155/2016/1870305. (abstract)
Mohammadi N, Scannell AGM, Silva-Espinoza MA. Avenanthramides as digestion-stage modulators: Mechanistic links across the gastrointestinal continuum.. Food Chem X. 2026. PMID 42712909. DOI 10.1016/j.fochx.2026.104252. (abstract)
Musa-Veloso K, Noori D, Venditti C, Poon T, et al.. A Systematic Review and Meta-Analysis of Randomized Controlled Trials on the Effects of Oats and Oat Processing on Postprandial Blood Glucose and Insulin Responses.. J Nutr. 2021. PMID 33296453. DOI 10.1093/jn/nxaa349. (abstract)
Reynolds A, Mann J, Cummings J, Winter N, et al.. Carbohydrate quality and human health: a series of systematic reviews and meta-analyses.. Lancet. 2019. PMID 30638909. DOI 10.1016/S0140-6736(18)31809-9. (abstract)
Shen XL, Zhao T, Zhou Y, Shi X, et al.. Effect of Oat β-Glucan Intake on Glycaemic Control and Insulin Sensitivity of Diabetic Patients: A Meta-Analysis of Randomized Controlled Trials.. Nutrients. 2016. PMID 26771637. DOI 10.3390/nu8010039. (abstract)
Wehrli F, Taneri PE, Bano A, Bally L, et al.. Oat Intake and Risk of Type 2 Diabetes, Cardiovascular Disease and All-Cause Mortality: A Systematic Review and Meta-Analysis.. Nutrients. 2021. PMID 34444718. DOI 10.3390/nu13082560. (abstract)
Whitehead A, Beck EJ, Tosh S, Wolever TM. Cholesterol-lowering effects of oat β-glucan: a meta-analysis of randomized controlled trials.. Am J Clin Nutr. 2014. PMID 25411276. DOI 10.3945/ajcn.114.086108. (abstract)
Zhang X, Sun H, Tao B, Li Z, et al.. Avenanthramides in Obesity-Related Metabolic Dysfunction: Mechanisms, Evidence Attribution, and Translational Priorities.. Nutrients. 2026. PMID 42797048. DOI 10.3390/nu18183066. (abstract)
. US Code of Federal Regulations, 21 CFR 101.81: Health claims: soluble fiber from certain foods and risk of coronary heart disease (text shown by Cornell Legal Information Institute). . . (full-text)
. US FDA: Questions and Answers on the Gluten-Free Labeling of Foods. . . (full-text)
. GBIF Backbone Taxonomy: Avena sativa L. (usageKey 2705290). . . (full-text)
. NHS (UK): Coeliac disease. . . (full-text)
. NIDDK (US National Institutes of Health): Symptoms and Causes of Gas in the Digestive Tract. . . (full-text)
. USDA FoodData Central: Cereals, oats, regular and quick, not fortified, dry (FDC 173904, SR Legacy, April 2018 release; item last updated 4/1/2019). . . (full-text)
. USDA FoodData Central: Cereals, oats, regular and quick, unenriched, cooked with water (includes boiling and microwaving), without salt (FDC 173905, SR Legacy; item last updated 4/1/2019). . . (full-text)
. WHO fact sheet: Mycotoxins (2 October 2023). . . (full-text)

Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.